Information  X 
Enter a valid email address

Homeserve Plc (HSV)

  Print      Mail a friend       Annual reports

Wednesday 26 June, 2019

Homeserve Plc

Director/PDMR Shareholding

RNS Number : 4842D
Homeserve Plc
26 June 2019
 

HomeServe plc

 

Investment and Grant of Awards under the

HomeServe 2018 Long Term Incentive Plan (the 'LTIP')

 

A number of Directors have been granted Performance Awards under the LTIP. No consideration was payable for the grant of the Awards.  Performance Awards will vest in three years' time subject to continued employment and the achievement of stretching performance criteria relating to EPS and comparative TSR. 

 

Details of the Performance Awards are as follows:

 

Name

Status

No of Shares subject to Performance  Award

Richard Harpin

Director

74,438

David Bower

Director

47,468

Tom Rusin

Director

83,924

 

Certain Directors have also been invited to invest some of their FY19 net annual bonus in Shares ("Investment Shares") under the LTIP.  Investment Shares were purchased on 25 June 2019 at a price of £11.9416 per Share.

 

Following the acquisition of Investment Shares, these individuals were granted Matching Awards under the LTIP, to acquire Shares. No consideration was paid for the grant of Matching Awards (other than the acquisition of linked Investment Shares). Subject to the retention of the Investment Shares, continued employment and the achievement of stretching EPS and comparative TSR related performance criteria, the Matching Awards will vest in three years' time. 

 

Details of the Investment Shares and Matching Awards are set out in the table below.

 

Name

Status

No of Investment Shares purchased

No of  Shares subject to Matching  Award

Richard Harpin

Director

18,935

71,453

David Bower

Director

10,809

40,789

Tom Rusin

Director

16,438

62,030

 

 

26 June 2019

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEAPKKADXNEEF

a d v e r t i s e m e n t